Furthermore, the overexpressed MMP2 in tumor tissues degraded the responsive peptides in the nanoparticles, triggering their disintegration in the extracellular environment and subsequent release of the encapsulated protein drugs. The gene discussed is MMP2; the disease is neoplasm.